The Ministry of Commerce and Industry, under the Department for Promotion of Industry and Internal Trade, has introduced draft amendments to the Patents Rules, 2003. These drafts detail various changes proposed by the Central Government, anchored on section 159 of the Patents Act, 1970. The government seeks to amend the …
An Indonesian plantation company has filed the first patent applications for a hybrid variety of palm oil seeds and their production that it expects will increase the crop's yield by several hundred per cent. London Sumatra, a British-founded company now part of the Indofood Group, is confident the new hybrid …
Business Standard / New Delhi October 1, 2008, 0:09 IST One more round has started in the battle between drug patent holders and generics players with Swiss firm Hoffman-La Roche filing a patent infringement suit against Indian generics leader Cipla for launching a copy of its anti-infection drug Valcyte. This …
Despite numerous international commitments to promote transfer of climate-change related technologies to developing countries, such transfers are not occurring at a sufficient rate to aid these nations in mitigating and adapting to the effects of climate change. The impact of the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights …
Intellectual property rights have been high on the policy agenda in recent years. Understanding the evolution and use of the patent system is critical to understanding policy debates, including the role of intellectual property in economic growth and development, and the relationship between IP policy and key public policy concerns, …
PATENTLY ABSURD Latha Jishnu / New Delhi September 17, 2008, 3:35 IST There was groundbreaking news from Japan five days ago. Scientists from Kyoto University were awarded a patent for their discovery on how to produce stem cells from skin, the first stem cell patent granted in Japan. The special …
Reema Narendran |THIRUVANANTHAPURAM: Without a thought to the human effort, time and money put into its validation, two tribal medicines developed in the state are disappearing into nothingness, while multinational pharma companies walk away with the patents and trademark rights. On the one hand is Jeevani, which has already lost …
Intellectual property occupies a central position in the biotechnology innovation system, the expected source of new medicines, foods and bio-energy. An international and interdisciplinary research team has convened for the last seven years in an attempt to better understand the mechanisms of intellectual property in biotechnology innovation, and to suggest …
Courtesy earthworms, hair, weed easily converted to manure in 2003, the government ordered the closure of several hair processing units, which made wigs, in Karnataka because of pollution. Burning of hair resulted in toxic elements, which caused allergies. The problem with human hair is it takes hundreds of years to …
Joe C Mathew / New Delhi August 27, 2008, 0:39 IST Firm reaches out-of-court agreement on 5 of 19 patent challenges in the US. Ranbaxy Laboratories, India's largest pharmaceutical drug firm by sales, expects its recent patent litigation settlements to add significantly to its revenues as well as net profit. …
the Drugs Controller General of India (dcgi) is preparing guidelines for linking the drug regulatory authority and the Indian patent office. The system called
P B Jayakumar / Mumbai July 29, 2008, 5:18 IST Dr Reddy's Laboratories, the country's third-biggest drugmaker, will form a joint venture with one of the world's biggest biotech companies to make biosimilars or generic versions of patented biotech drugs to take on Ranbaxy Laboratories, Reliance Life Sciences, among other …
PATENTLY ABSURD Latha Jishnu / New Delhi July 23, 2008, 0:26 IST Some extraordinary initiatives have been launched in recent times to ensure that the poorest of the world have access to medicines to fight pandemics and life-threatening diseases. One such is UNITAID, an international drug purchase facility that brings …
Pb Jayakumar / Mumbai July 18, 2008, 0:40 IST US-based Abbot Laboratories has filed a suit against Dr Reddy's Laboratories for infringing the patent of Depakote ER, an anti-seizure or epilepsy drug with sales of over $1.48 billion (more than s 6,000 crore) in the American market. The lawsuit was …
The Ranbaxy sale to Daiichi Sankyo could herald a new phase in the evolution of the Indain pharmaceutical industry. In order to cope in a world after the agreement on Trade-related Aspects of Intellectual Property Rights came into force, some of the larger Indian firms pursued the two strategies of …
Today's world trade volume is 27 times that of 1950. Trade liberalisation has made no small contribution to global warming due to spectacular growth in the transportation industry. Today, when they need to negotiate the climate regime to replace the Kyoto Protocol after 2012, industrial and developing countries bicker over …
SUN Pharmaceutical Industries, the country's most valuable drugmaker, has decided to launch a hostile bid for Israel's Taro Pharmaceutical Industries. This is a rare instance of an Indian company making an unsolicited bid for a foreign firm. The move follows Taro's rejection of a merger agreement with Sun last month. …
Has Malvinder Singh truly freed Ranbaxy from risk by opting for an out-of-court settlement with Pfizer over Lipitor as he has claimed? The markets and analysts certainly thought otherwise. Investors dumped the Ranbaxy stock last week after the company announced that it had closed the feud with Pfizer over cholesterol …
In a decision that will go a long way in soothing people living with HIV/AIDS (PLHAs), the Indian patent office today turned down the claim of a drug company to patent nevirapine. The drug is critical to HIV/AIDS treatment strategy, and is a crucial part of treatment for children affected …
Subject to the approval of the shareholders and the usual regulatory and statutory rubber stamps, India's largest pharmaceutical company, Ranbaxy Laboratories, is expected, by the end of March 2009 to become a subsidiary of Daiichi Sankyo, one of the leading pharmaceutical companies of Japan. Ranbaxy came into existence in 1937 …
